Bedrijven (2)

ANNEXIN PHARMACEUTICALS AB 9 M $
Logo Annexin Pharmaceuticals AB

Annexin Pharmaceuticals AB (publ) is een in Zweden gevestigd biotechnologiebedrijf. Haar belangrijkste product is ANXV, een menselijk recombinant eiwit Annexine A5, voor de noodbehandeling van patiënten met hart- en vaatziekten met schade aan de bloedvate ...

ANNEXIN PHARMACEUTICALS AB (PUBL) 9 M $
Logo Annexin Pharmaceuticals AB (publ)

Annexin Pharmaceuticals AB (publ) is een in Zweden gevestigd biotechnologiebedrijf. Haar belangrijkste product is ANXV, een menselijk recombinant eiwit Annexine A5, voor de noodbehandeling van patiënten met hart- en vaatziekten met schade aan de bloedvate ...


Insiders

Mikael Dolsten
Mikael Dolsten

Mikael Dolsten bekleedt de functie van Chief Scientific Officer & Research President bij Pfizer Inc. Dr. Dolsten is ook lid van de raad van bestuur van de New York Academy of Sciences, Karyopharm Therapeutics, Inc. en PhRMA Foundation en lid van de Royal Swedish Academy of Engineering Sciences en lid van Government-University-Industry Research Roundtable. In het verleden was hij Principal bij OrbiMed Advisors LLC en Partner bij OrbiMed Advisors Private Equity (een dochteronderneming van OrbiMed Advisors LLC), President voor Wyeth Research, EVP, Global Head-Pharma Research & Discovery bij Boehringer Ingelheim Pharmaceuticals, Inc., Senior Vice President voor Wyeth Corp. en Member-Benefits, Law & Regulatory Committee bij Wyeth Pharmaceuticals LLC. Dr. Dolsten behaalde een doctoraat aan de Universiteit van Lund.


Foto Mikael Lyngsø
Mikael Lyngsø

Mikael Lyngsø is currently the Chief Executive Officer at Stibo Catalog A since 1995 and the Director at Hesehus A since 2019.
He previously worked as the Chief Executive Officer at Stibo Systems A, Director at Stibo Systems Ltd., and Software Developer at CCI Europe A.
Mr. Lyngsø completed his undergraduate degree from the University of Aarhus in 1989.



Foto Mikael Munksgaard
Mikael Munksgaard

Mikael Venø Munksgaard is currently working as Vice President & Portfolio Manager Corporate Bonds at Jyske Bank A since 2006.
Prior to this, he worked as Vice President & Portfolio Manager at Jyske Invest Fund Management A.



Foto Mikael Lorsell
Mikael Lorsell

Mr. Mikael H.
Lorsell is a Portfolio Manager at Alcur Fonder AB.
Mr. Lorsell was previously employed as an Analyst by Danske Bank A/S (Sweden), a Research Analyst by Erik Penser Bank AB, and a Research Analyst by Swedbank AB (Broker).
He has a bachelor's degree in economics from Stockholm University.



Foto Mikael Sandström
Mikael Sandström

Mikael Sandström worked as the Head of Products & Administrator at Cicero Fonder AB from 2015 to 2016.


Foto Mikael Bo Larsen
Mikael Bo Larsen

Mikael Bo Larsen is currently working as a Senior Investor Relations Officer at Alm.
Brand A, as well as the Head of Information & Technology at Thyregod Bygningsindustri A, and the Head of Investor Relations at TORM Plc.
In the past, he has worked as the Director of Investor Relations at Carlsberg A and Carlsberg Breweries A.


Geen resultaten voor deze zoekopdracht